Physician profile
Eric Simmons
NPI 1487815684
$2,017.79
in general payments reported to CMS, 2019-2025
25 companies · $853 in 2025
The $853 reported for 2025 was more than what 85% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2021: $234 · 2022: $288 · 2024: $193 · 2025: $853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $232.83 | 2019-2022 | |
| Bioventus LLC | $192.65 | 2024 | Exogen Ultrasound Bone Healing System |
| Lifenet Health | $172.46 | 2025 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $144.10 | 2021 | |
| Globus Medical, INC. | $139.78 | 2025 | Senza |
| Linvatec Corporation | $136.69 | 2025 | Rts, Neospan, Biobrace 23mm |
| In2bones USA, LLC | $134.24 | 2019 | |
| Grt US Holding, INC. | $107.14 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $97.37 | 2025 | |
| Cardiovascular Systems INC. | $93.70 | 2019-2022 | |
| Djo, LLC | $77.13 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $75.95 | 2021 | |
| Smith+Nephew, INC. | $74.78 | 2025 | Stravix, Grafix Pl, Grafix |
| Biowound Solutions, INC. | $69.64 | 2025 | Bio-Connekt |
| Amgen INC. | $66.91 | 2025 | Krystexxa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $41.57 | 2019 | |
| Osteocentric Technologies, INC. | $37.85 | 2019 | |
| Molnlycke Health Care US, LLC | $19.50 | 2025 | Exufiber, Mepitel, Mepilex Border Flex |
| Organogenesis INC. | $17.38 | 2025 | Apligraf |
| Ibsa Pharma INC. | $17.24 | 2025 | Licart, Flector, Tirosint |
| Solventum Corporation | $15.47 | 2025 | Promogran Prisma |
| Musculoskeletal Transplant Foundation INC. | $14.02 | 2021 | |
| Arthrosurface Incorporated | $13.96 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.52 | 2025 | Nuzyra |
| Advanced Oxygen Therapy INC. | $11.91 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.